Squarepoint Ops LLC Sells 28,687 Shares of Revvity, Inc. (NYSE:RVTY)

Squarepoint Ops LLC cut its holdings in shares of Revvity, Inc. (NYSE:RVTY) by 89.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,344 shares of the company’s stock after selling 28,687 shares during the period. Squarepoint Ops LLC’s holdings in Revvity were worth $351,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the business. Janus Henderson Group PLC boosted its holdings in shares of Revvity by 3.9% in the first quarter. Janus Henderson Group PLC now owns 5,664,528 shares of the company’s stock valued at $594,769,000 after buying an additional 210,100 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Revvity by 18.5% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,126,271 shares of the company’s stock worth $223,258,000 after buying an additional 332,632 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Revvity by 5.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,149,122 shares of the company’s stock valued at $120,506,000 after buying an additional 57,656 shares during the last quarter. Ceredex Value Advisors LLC boosted its position in Revvity by 2.2% during the 2nd quarter. Ceredex Value Advisors LLC now owns 1,094,938 shares of the company’s stock worth $114,815,000 after acquiring an additional 23,318 shares during the last quarter. Finally, RGM Capital LLC grew its stake in shares of Revvity by 6.7% during the 2nd quarter. RGM Capital LLC now owns 950,858 shares of the company’s stock worth $99,707,000 after acquiring an additional 59,994 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. TD Cowen upped their price objective on Revvity from $130.00 to $141.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. Barclays increased their price target on shares of Revvity from $115.00 to $125.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 30th. Jefferies Financial Group upped their target price on shares of Revvity from $115.00 to $125.00 and gave the company a “hold” rating in a report on Monday, July 29th. Citigroup lifted their price target on Revvity from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, July 30th. Finally, Leerink Partners began coverage on Revvity in a research report on Monday, July 8th. They set an “outperform” rating and a $125.00 price target on the stock. Eight analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Revvity presently has an average rating of “Moderate Buy” and an average target price of $125.53.

Revvity Stock Down 1.1 %

RVTY opened at $120.23 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.98 and a current ratio of 2.27. The stock has a fifty day moving average of $121.49 and a 200-day moving average of $112.21. Revvity, Inc. has a fifty-two week low of $79.50 and a fifty-two week high of $128.15. The company has a market capitalization of $14.84 billion, a P/E ratio of 99.36, a P/E/G ratio of 2.90 and a beta of 1.05.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, July 29th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.10. Revvity had a net margin of 6.26% and a return on equity of 7.34%. The firm had revenue of $691.70 million for the quarter, compared to analyst estimates of $690.33 million. During the same quarter in the prior year, the business posted $1.21 EPS. The business’s revenue was down 2.5% compared to the same quarter last year. On average, equities analysts expect that Revvity, Inc. will post 4.75 EPS for the current year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Friday, October 18th will be issued a $0.07 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.28 annualized dividend and a yield of 0.23%. Revvity’s dividend payout ratio is presently 23.14%.

Insider Activity

In other Revvity news, insider Tajinder S. Vohra sold 2,154 shares of the company’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $121.73, for a total transaction of $262,206.42. Following the completion of the sale, the insider now directly owns 19,652 shares in the company, valued at $2,392,237.96. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, insider Tajinder S. Vohra sold 2,154 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $121.73, for a total transaction of $262,206.42. Following the completion of the transaction, the insider now directly owns 19,652 shares in the company, valued at $2,392,237.96. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Joel S. Goldberg sold 3,500 shares of the business’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total value of $412,510.00. Following the sale, the insider now owns 33,400 shares in the company, valued at $3,936,524. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 7,807 shares of company stock worth $937,576. 0.60% of the stock is currently owned by company insiders.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.